Bradley Foster & Sargent Inc Cytosorbents Corp Transaction History

Bradley Foster & Sargent Inc

$5.82 Billion
Q3 2024

A detailed history of Bradley Foster & Sargent Inc transactions in Cytosorbents Corp stock. As of the latest transaction made, Bradley Foster & Sargent Inc holds 10,000 shares of CTSO stock, worth $8,400. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,000

Previous 10,000 -0.0%

Holding current value

$8,400

Previous $7,000 114.29%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 08, 2023	SELL	$1.79 - $4.17 $3,580 - $8,340	-2,000 Reduced 16.67%	10,000 $33,000
Q4 2022 Feb 14, 2023	BUY	$1.03 - $2.03 $2,060 - $4,059	2,000 Added 20.0%	12,000 $18,000
Q1 2022 May 16, 2022	SELL	$2.88 - $4.23 $720 - $1,057	-250 Reduced 2.44%	10,000 $32,000
Q4 2021 Mar 11, 2022	SELL	$4.05 - $8.11 $97,159 - $194,558	-23,990 Reduced 70.06%	10,250 $43,000
Q3 2021 Nov 10, 2021	SELL	$7.0 - $9.71 $45,500 - $63,115	-6,500 Reduced 15.95%	34,240 $278,000
Q2 2021 Aug 19, 2021	BUY	$7.55 - $9.42 $6,523 - $8,138	864 Added 2.17%	40,740 $308,000
Q1 2021 Apr 26, 2021	BUY	$8.23 - $11.48 $6,057 - $8,449	736 Added 1.88%	39,876 $346,000
Q3 2020 Oct 26, 2020	BUY	$7.37 - $11.54 $46,062 - $72,125	6,250 Added 19.0%	39,140 $312,000
Q1 2020 May 07, 2020	SELL	$3.77 - $7.73 $1,127 - $2,311	-299 Reduced 0.9%	32,890 $254,000
Q4 2019 Jan 29, 2020	SELL	$3.61 - $5.22 $44,431 - $64,247	-12,308 Reduced 27.05%	33,189 $128,000
Q3 2019 Oct 30, 2019	SELL	$4.33 - $7.63 $317,189 - $558,928	-73,254 Reduced 61.69%	45,497 $229,000
Q2 2019 Aug 08, 2019	SELL	$5.92 - $7.78 $78,505 - $103,170	-13,261 Reduced 10.05%	118,751 $785,000
Q1 2019 May 02, 2019	SELL	$6.82 - $8.56 $122,528 - $153,788	-17,966 Reduced 11.98%	132,012 $999,000
Q4 2018 Jan 30, 2019	BUY	$7.05 - $12.64 $38,676 - $69,343	5,486 Added 3.8%	149,978 $1.21 Million
Q3 2018 Oct 31, 2018	BUY	$10.95 - $14.8 $53,939 - $72,904	4,926 Added 3.53%	144,492 $1.86 Million
Q2 2018 Jul 31, 2018	BUY	$6.9 - $12.35 $963,005 - $1.72 Million	139,566 New	139,566 $1.59 Million

Others Institutions Holding CTSO

# of Institutions

Shares Held

16.7M

Call Options Held

15.4K

Put Options Held

View Full List

About Cytosorbents Corp

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $36.6M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

More about CTSO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bradley Foster & Sargent Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bradley Foster & Sargent Inc with notifications on news.

Account

Bradley Foster & Sargent Inc Cytosorbents Corp Transaction History